128 related articles for article (PubMed ID: 8824714)
1. Reactivity of islet cell antibodies (ICA) to recombinant glutamic acid decarboxylase (GAD).
Guazzarotti L; Thivolet C; Tardivel I; Chevalier A; Carel JC
J Autoimmun; 1995 Dec; 8(6):901-14. PubMed ID: 8824714
[TBL] [Abstract][Full Text] [Related]
2. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
3. Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus.
Rickert M; Seissler J; Dangel W; Lorenz H; Richter W
Clin Chem; 2001 May; 47(5):926-34. PubMed ID: 11325898
[TBL] [Abstract][Full Text] [Related]
4. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
[TBL] [Abstract][Full Text] [Related]
5. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
[TBL] [Abstract][Full Text] [Related]
8. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.
Petersen JS; Hejnaes KR; Moody A; Karlsen AE; Marshall MO; Høier-Madsen M; Boel E; Michelsen BK; Dyrberg T
Diabetes; 1994 Mar; 43(3):459-67. PubMed ID: 8314020
[TBL] [Abstract][Full Text] [Related]
9. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
[TBL] [Abstract][Full Text] [Related]
10. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T
Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.
Martino GV; Tappaz ML; Braghi S; Dozio N; Canal N; Pozza G; Bottazzo GF; Grimaldi LM; Bosi E
J Autoimmun; 1991 Dec; 4(6):915-23. PubMed ID: 1812896
[TBL] [Abstract][Full Text] [Related]
12. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes.
Atkinson MA; Kaufman DL; Newman D; Tobin AJ; Maclaren NK
J Clin Invest; 1993 Jan; 91(1):350-6. PubMed ID: 8423231
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings.
Korhonen S; Knip MM; Kulmala P; Savola K; Akerblom HK; Knip M;
Diabetes Metab Res Rev; 2002; 18(1):43-8. PubMed ID: 11921417
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA
J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
[TBL] [Abstract][Full Text] [Related]
15. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
Akawaza S; Kawasaki E; Yano M; Abiru N; Yamaguchi Y; Nagataki S
Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.
Imagawa A; Itoh N; Hanafusa T; Katsura H; Yamaguchi A; Takeda A; Iwahashi H; Nakajima H; Miyagawa J; Namba M; Kuwajima M; Matsuzawa Y
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):43-52. PubMed ID: 8733827
[TBL] [Abstract][Full Text] [Related]
19. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
De Aizpurua HJ; French MB; Chosich N; Harrison LC
J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
[TBL] [Abstract][Full Text] [Related]
20. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]